So frustrating
The two most studied incretins, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) stimulate insulin release through specific G-protein-coupled receptors predominantly found on islet cells
The method demonstrates high sensitivity, selectivity, and reproducibility, suitable for complex biological matrices and aligned with regulatory expectations
Because the treated fat cells are permanently removed, results can be long-lasting when combined with a healthy lifestyle
This ingredient has a low sensitization risk and testing shows it does not classify as a skin irritant or sensitizer
In summary, semaglutide has proven to be a pinnacle of GLP-1 drug development so far: highly efficacious for glycemic control, capable of inducing substantial weight loss, and demonstrating broad benefits (cardiovascular, renal, and beyond)